Medigen Vaccine Biologics (ROCO:6547) FCF Margin %: 66.35% (As of Dec. 2025)


ROCO:6547 Medigen Vaccine Biologics Corp ROCO:6547
68 GF Score
Price NT$45.45
GF Value NT$69.49
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Medigen Vaccine Biologics FCF Margin %?

Medigen Vaccine Biologics ROCO:6547 -0.44% 68 FCF Margin % is 66.35% as of Dec. 2025. GuruFocus rates ROCO:6547 with a GF Score™ of 68/100 and a GF Value™ of NT$69.49 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 959 Biotechnology companies, Medigen Vaccine Biologics ranks better than 64.86% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Medigen Vaccine Biologics's Free Cash Flow for the three months ended in Dec. 2025 was NT$97.5 Mil. Medigen Vaccine Biologics's Revenue for the three months ended in Dec. 2025 was NT$147.0 Mil. Therefore, Medigen Vaccine Biologics's FCF Margin % for the quarter that ended in Dec. 2025 was 66.35%.

As of today, Medigen Vaccine Biologics's current FCF Yield % is -0.68%.

The historical rank and industry rank for Medigen Vaccine Biologics's FCF Margin % or its related term are showing as below:

ROCO:6547' s FCF Margin % Range Over the Past 10 Years
Min: -51787.77   Med: -134.36   Max: 13.56
Current: -16.45

During the past 13 years, the highest FCF Margin % of Medigen Vaccine Biologics was 13.56%. The lowest was -51787.77%. And the median was -134.36%.

ROCO:6547's FCF Margin % is ranked better than
64.86% of 959 companies
in the Biotechnology industry
Industry Median: -84.65 vs ROCO:6547: -16.45

Medigen Vaccine Biologics FCF Margin % Related Terms

Medigen Vaccine Biologics FCF Margin % Historical Data

* Premium members only.

The historical data trend for Medigen Vaccine Biologics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medigen Vaccine Biologics FCF Margin % Chart

Medigen Vaccine Biologics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.56 -370.96 -134.36 0.95 -16.45

Medigen Vaccine Biologics Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 130.66 -71.83 -57.28 -15.79 66.35

ROCO:6547 vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, Medigen Vaccine Biologics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medigen Vaccine Biologics FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medigen Vaccine Biologics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Medigen Vaccine Biologics's FCF Margin % falls into.


ROCO:6547
68GF Score
Medigen Vaccine Biologics Corp ROCO:6547
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medigen Vaccine Biologics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Medigen Vaccine Biologics's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-100.865/613.171
=-16.45 %

Medigen Vaccine Biologics's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=97.543/147.013
=66.35 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 66.35% mean?
Medigen Vaccine Biologics (ROCO:6547) has a FCF Margin % of 66.35% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Medigen Vaccine Biologics and its competitors. According to the industry distribution chart, Medigen Vaccine Biologics ranks #337 out of 959 companies in the Biotechnology industry, placing it in the top 35.1%.
Is Medigen Vaccine Biologics' FCF Margin % too high?
Medigen Vaccine Biologics' current FCF Margin % is 66.35%. Based on the distribution chart, Medigen Vaccine Biologics ranks #337 out of 959 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Medigen Vaccine Biologics has a GF Score™ of 68/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Medigen Vaccine Biologics' FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Medigen Vaccine Biologics ranks #337 out of 959 companies for FCF Margin %. This puts Medigen Vaccine Biologics in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Medigen Vaccine Biologics and its competitors. Medigen Vaccine Biologics's current FCF Margin % is 66.35%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medigen Vaccine Biologics stock overvalued right now?
Based on GuruFocus' analysis, Medigen Vaccine Biologics (ROCO:6547) is currently considered Possible Value Trap. The stock's GF Value™ is NT$69.49, compared to a current price of NT$45.45 — trading 34.6% below its estimated fair value. The current FCF Margin % is 66.35%. Medigen Vaccine Biologics' overall GF Score™ is 68/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Medigen Vaccine Biologics (ROCO:6547), the current FCF Margin % is 66.35% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medigen Vaccine Biologics (ROCO:6547) Overvalued in 2026?

Based on GuruFocus' analysis, Medigen Vaccine Biologics stock appears to be undervalued. The current stock price of NT$45.45 is trading 34.6% below its estimated GF Value™ of NT$69.49. GuruFocus considers Medigen Vaccine Biologics to be Possible Value Trap.

Key valuation signals for ROCO:6547:

  • FCF Margin %: 66.35%
  • GF Value™: NT$69.49 vs. price of NT$45.45 (34.6% below fair value)
  • GF Score™: 68/100 with 2 warning signs

No single metric tells the full story. See the ROCO:6547 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medigen Vaccine Biologics Business Description

Address 302 No. 68, Shengyi 3rd Road, Hsinchu County, Zhubei, TWN, 30261
Medigen Vaccine Biologics Corp is engaged in the research, development and wholesale of vaccine and biopharmaceutical, medical devices wholesale and retail, etc. Its products include dengue vaccine, anti-RSV biosimilars, COVID-19 vaccines, enterovirus A71 vaccine, and influenza vaccine QIZ. It operates business only in a single industry in Taiwan.
68GF Score

Get the complete analysis for ROCO:6547

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$45.45
Price
NT$69.49
GF Value